Cansortium Inc. (OTCMKTS:CNTMF – Get Rating) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 210,200 shares, a decline of 9.6% from the July 15th total of 232,500 shares. Based on an average trading volume of 246,800 shares, the days-to-cover ratio is currently 0.9 days.

Cansortium Price Performance

Shares of Cansortium stock opened at $0.16 on Thursday. The firm has a 50-day moving average of $0.18 and a 200-day moving average of $0.30. Cansortium has a 52-week low of $0.13 and a 52-week high of $0.91.

Get Cansortium alerts:

Cansortium Company Profile

(Get Rating)

Cansortium Inc, through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles.

Featured Articles

• Get a free copy of the StockNews.com research report on Cansortium (CNTMF)
• Which Semiconductor Stocks Are Ready For Big Price Moves?
• Miners Advance On Earnings Despite Broader Economic Challenges
• Agilent Technologies Proves Its Worth VS Illumina
• Lowe's Stands Out Amid Q2 Retail Reports
• Target's Results Cap Upside Potential For Retail Stocks

Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.